Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bempedoic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 925Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Untitled Letter Skewers Esperion's Nexlizet TV Ad
    FDA Untitled Letter Skewers Esperion's Nexlizet TV Ad

    07 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/fda-untitled-letter-skewers-esperions-claims-about-cholesterol-med-nexlizet-tv-ad

    FIERCE PHARMA
    07 Jan 2026
    Share Share
    HLS Therapeutics's Nilemdo Approved in Canada
    HLS Therapeutics's Nilemdo Approved in Canada

    14 Nov 2025

    // HEALTH CANADA

    https://pdf.hres.ca/dpd_pm/00082429.PDF

    HEALTH CANADA
    14 Nov 2025
    Share Share
    Alkem’s Generics Bempedoic Acid Receives Tentative Approval In US
    Alkem’s Generics Bempedoic Acid Receives Tentative Approval In US

    04 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219416

    FDA
    04 Nov 2025
    Share Share
    Alkem’s Generics Bempedoic Acid Receives Tentative Approval in US
    Alkem’s Generics Bempedoic Acid Receives Tentative Approval in US

    23 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219421

    FDA
    23 Oct 2025
    Share Share
    Daiichi Starts Development of Oral Triple Lipid-Lowering Combo
    Daiichi Starts Development of Oral Triple Lipid-Lowering Combo

    31 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250830562434/en/Daiichi-Sankyo-Announces-the-Initiation-of-the-Development-of-Oral-Triple-Combination-Lipid-Lowering-Tablets-to-Support-the-Management-of-LDL-C

    BUSINESSWIRE
    31 Aug 2025
    Share Share
    Esperion (ESPR) Reaches Settlement to Protect Nexletol Patents
    Esperion (ESPR) Reaches Settlement to Protect Nexletol Patents

    02 Jun 2025

    // GURUFOCUS

    https://www.gurufocus.com/news/2901186/esperion-espr-reaches-settlement-to-protect-nexletol-patents-espr-stock-news

    GURUFOCUS
    02 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.